Combo with mk2206 makes a lot of sense - when you inhibit mTor, Akt gets upregulated and much of the impact of inhibiting mTor is lost. So combo with an Akt inhibitor could be very promising.
I don't understand the combo with Notch though, although this isn't something I've ever looked at. I think Notch and Mtor are basically on the same pathway.
Bottom line though is that this shows MRK is taking this drug very seriously and are doing a very thorough job. Good thing Aria isn't still on the hook for co-development costs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.